Wire Stories
345KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group
Transaction marks KKR’s latest and largest credit investment in India MUMBAI, India–(BUSINESS WIRE)–KKR, a leading global investment firm, and Manipal Education and...
- 327
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting Korea’s Expanding Influence in Global Biotech Innovation...
- 304
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration...
- 395
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#AI—SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), announces three software...
- 421
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting
– Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with small cell lung cancer (SCLC) across dose...
- 386
James Hardie Industries plc Announces Proposed Private Offering of Senior Secured Notes
SYDNEY–(BUSINESS WIRE)–James Hardie Industries plc (ASX: JHX) (“James Hardie†or the “Companyâ€) announced today that its wholly-owned subsidiary, JH North America Holdings...
- 305
AEye’s Apollo Lidar Sensor Wins Prestigious AIIA Intelligent Perception Industry Leadership Award
PLEASANTON, Calif.–(BUSINESS WIRE)–AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, announced today that its flagship 1550 nm lidar...
- 354
ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three years First trial in more than a...
- 324
UiPath Partners with HCLTech to Accelerate Agentic Automation for Global Enterprises
NEW YORK & NOIDA, India–(BUSINESS WIRE)–UiPath (NYSE: PATH), a global leader in agentic automation, today announced a strategic partnership with HCLTech, a...
- 411
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#ZenoTOF–At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR),...
